Literature DB >> 28476242

Evaluation of the carbapenem inactivation method (CIM) for detecting carbapenemase activity in enterobacteria.

A Aguirre-Quiñonero1, M E Cano2, D Gamal3, J Calvo2, L Martínez-Martínez4.   

Abstract

OBJECTIVES: The objective of this study was to evaluate the accuracy of the CIM test in the detection of carbapenemase activity in 124 strains of Enterobacteriaceae.
METHODS: A panel of 124 previously characterized Enterobacteriaceae was tested: 77 strains producing the following carbapenemase families: KPC (n = 14), GES (n = 22), NDM (n = 19), VIM (n = 4), IMP (n = 4) and OXA-48 (n = 14) and 47 non-carbapenemase producers. For the CIM method, an active susceptibility meropenem disc was exposed to a bacterial suspension of a test strain; when a carbapenemase is produced, the antibiotic is inactivated allowing uninhibited growth of an indicator strain after overnight incubation. A clear inhibition zone (≥20 mm) was considered indicative of no-carbapenemase activity.
RESULTS: All KPC, NDM, VIM, IMP or OXA-48 producing strains were unequivocally detected with the CIM test. CIM false negative results were obtained with eleven Enterobacter cloacae producing GES-6. Two other E. cloacae not producing carbapenemase (one with SHV-12, one hyperproducing AmpC) were positive by the test. The sensitivity and specificity of the assay compared to those of molecular methods were 85.7% and 95.7%, respectively.
CONCLUSIONS: The CIM method proved to be inexpensive and easy to interpret. It provided less than optimal results in the detection of GES-6 activity.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenem inactivation method; Carbapenemase; GES-6; Rapid test

Mesh:

Substances:

Year:  2017        PMID: 28476242     DOI: 10.1016/j.diagmicrobio.2017.03.009

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus.

Authors:  François Caméléna; Aurélie Cointe; Vincent Mathy; Claire Hobson; Catherine Doit; Béatrice Bercot; Dominique Decré; Isabelle Podglajen; Laurent Dortet; Audrey Monjault; Philippe Bidet; Stéphane Bonacorsi; André Birgy
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

2.  Rapid Detection and Characterization of Carbapenemases in Enterobacterales with a New Modified Carbapenem Inactivation Method, mCIMplus.

Authors:  Morgane Petit; François Caméléna; Aurélie Cointe; Thibaut Poncin; Manel Merimèche; Stéphane Bonacorsi; André Birgy; Béatrice Berçot
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

3.  Performance of a Novel Fluorogenic Assay for Detection of Carbapenemase-Producing Enterobacteriaceae from Bacterial Colonies and Directly from Positive Blood Cultures.

Authors:  Hoon Seok Kim; Jung Ok Kim; Ji Eun Lee; Kang Gyun Park; Hae Kyung Lee; Soo-Young Kim; Sun-Joon Min; Juhyeon Kim; Yeon-Joon Park
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

Review 4.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

5.  Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.

Authors:  Christian M Gill; Maxwell J Lasko; Tomefa E Asempa; David P Nicolau
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

6.  High Prevalence of Metallo-β-Lactamase-Producing Enterobacter cloacae From Three Tertiary Hospitals in China.

Authors:  Yimei Cai; Cha Chen; Mei Zhao; Xuegao Yu; Kai Lan; Kang Liao; Penghao Guo; Weizheng Zhang; Xingyan Ma; Yuting He; Jianming Zeng; Liang Chen; Wei Jia; Yi-Wei Tang; Bin Huang
Journal:  Front Microbiol       Date:  2019-08-09       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.